damia giovanna
机构: Chief, DNA repair unit, Mario negri institute
每年引用次数
引用次数
引用: 6,760
H-指数: 46
I10-指数 : 103
出版物: 226
Clinical research on the therapeutic effectiveness of a combination of sulfamethoxazole and a pyrimidine derivative. Comparison with the association of penicillin and streptomycin
Quaglia P , Damia G , Pilla G , Magliulo E
Clinica Terapeutica 52 ( 5) 417
1
1970
AACR-NCI-EORTC International conference--molecular targets and cancer therapeutics.
Damia G , D'Incalci M
IDrugs : the investigational drugs journal 4 ( 12) 1352
17
2001
Flavone acetic acid pharmacokinetics in nude mice.
Giavazzi R , Damia G , D'Incalci M , Garofalo A
Anticancer Research 10 437 -439
5
1990
Exploring the in vitro and in vivo activity of lucitanib in FGFR1-amplified lung cancer models
Ezia Bello , Rosaria Chilà , Federica Guffanti , Monique Zangarini
Cancer Research 74 ( 19_Supplement) 2670 -2670
1
2014
Luigi zyxwvutsrqponmlkji
Luisa DIOMEDE , Giovanna DAMIA , Maurizio D’INCALCI
Int. J. Cancer 59 581 -581
1994
ELISABETHMENU, LILIANAKAPLAN, GEORGESANDREU, LAUREDENVER, AND GE-RARD CHAOUAT. Immunoactive Products of Human Placenta:(I). An Immuno-regulatory Factor Obtained from Explant Cultures of Human Placenta Inhibits CTL Generation and Cytotoxic Effector Activity.(Received 6/29/88; accepted 12/13/S&)
PAOLA ALLAVENA , GIOVANNA DAMIA , TINA COLOMBO , DANIELA MAGGIONI
Cellular Immunology 119 242 -242
1989
ALDH enzymatic activity and CD133 positivity and response to chemotherapy in ovarian cancer patients.
Francesca Ricci , Sergio Bernasconi , Luca Porcu , Eugenio Erba
American Journal of Cancer Research 3 ( 2) 221 -229
15
2013
4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.
Massimo Broggini , Giulia Pennella , Cristina Geroni , Giovanna Damia
Cancer Research 61 ( 5) 1991 -1995
18
2001
Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
Robert H. Wiltrout , Francis W. Ruscetti , Giovanna Damia , Dan L. Longo
Cancer Research 52 ( 15) 4082 -4089
25
1992
Effects of recombinant transforming growth factor-beta 1 on hematologic recovery after treatment of mice with 5-fluorouracil.
Robert H. Wiltrout , Francis W. Ruscetti , Giovanna Damia , Dan L. Longo
Journal of Immunology 147 ( 10) 3342 -3347
14
1991
Establishment of patient-derived tumor xenograft models of mucinous ovarian cancer.
Giovanna Chiorino , Maddalena Fratelli , Patrizia Perego , Giovanna Damia
American Journal of Cancer Research 10 ( 2) 572 -580
2
2020
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma.
Giovanna Damia , Valentina Sancisi , Riccardo Bellazzi , Francesca Reggiani
Molecular Cancer 20 ( 1) 63 -63
2021
Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors
Emanuela Lovati , Giovanna Damia , Chiara Tarantelli , Anastasios Stathis
Blood Advances 5 ( 10) 2467 -2480
2021
Abstract A04: DNA double-strand break repair assay in primary cultures of patient-derived ovarian carcinoma xenografts.
Federica Guffanti , Julia Kaufmann , Francesca Bizzaro , Francesca Ricci
Clinical Cancer Research 22
2016
Risk/benefit profile of bevacizumab in metastatic colon cancer: A systematic review and meta-analysis
Elena Galfrascoli , Sheila Piva , Michela Cinquini , Antonio Rossi
Digestive and Liver Disease 43 ( 4) 286 -294
39
2011
DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas
Valentina Restelli , Monica Lupi , Rosaria Chilà , Micaela Vagni
Molecular Cancer Therapeutics 18 ( 7) 1255 -1264
8
2019
Unleashing Chk1 in cancer therapy.
Laura Carrassa , Giovanna Damia
Cell Cycle 10 ( 13) 2121 -2128
67
2011
Characterization of the 5’flanking Region of the Human chk1 Gene: Identification of E2F1 Functional Sites
Laura Carrassa , Massimo Broggini , Faina Vikhanskaya , Giovanna Damia
Cell Cycle 2 ( 6) 604 -609
37
2003
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype
Francesca Ricci , Sergio Bernasconi , Patrizia Perego , Monica Ganzinelli
Cell Cycle 11 ( 10) 1966 -1976
40
2012
Combined inhibition of Chk1 and Wee1: In vitro synergistic effect translates to tumor growth inhibition in vivo
Laura Carrassa , Rosaria Chilà , Monica Lupi , Francesca Ricci
Cell Cycle 11 ( 13) 2507 -2517
128
2012